CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Feb. 20,2025-- Harbour BioMed (HKEX: 02142,the "Company"),a global biopharmaceutical company committed to the discovery,development and co
RIYADH,Saudi Arabia,Feb. 20,2025-- The global launch event of theJETOUR T1 was held in Riyadh,on February 19th. This model,which adopts the new rugged aesthetic as its design language,is equipped with
$150 million of new money to boost liquidity, reduction of pre-transaction debt by over $75 million,andextended maturities dates to Q4 2029
YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1
MUNICH,Feb. 19,2025--On February 17,2025,GCL System Integration (GCL SI) achieved a significant milestone by securing the EcoVadis Group-level Silver Medal certification. In its first attempt,GCL SI s
ABU DHABI,UAE,Feb. 19,2025--With the countdown to the 2025 Formula 1® season underway,Ethara has officially launched ticket sales for the FORMULA 1® ETIHAD AIRWAYS ABU DHABI GRAND PRIX 2025,in
